These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 418444)

  • 21. The origin of blood k-hydroxyindoleacetic acid following L-hydrazino-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):613-6. PubMed ID: 3264918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I; Jensen TS; Rand JH; Van Woert MH
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Juorio AV
    Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression and potentiation of 5-hydroxytryptophan-induced hypoglycaemia by alpha-monofluoromethyldopa: correlation with the accumulation of 5-hydroxytryptamine in the liver.
    Endo Y
    Br J Pharmacol; 1987 Jan; 90(1):161-5. PubMed ID: 3493049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
    Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
    Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.
    Endo Y
    Br J Pharmacol; 1985 Jul; 85(3):591-8. PubMed ID: 3875380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats.
    Blundell JE; Latham CJ
    Pharmacol Biochem Behav; 1979 Oct; 11(4):431-7. PubMed ID: 316547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The maturational onset of the 5-HT mediated head twitch in mice.
    Eble JP; Goodrich C
    Physiol Behav; 1987; 41(1):47-51. PubMed ID: 3500481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of L-5-hydroxytryptophan (5-HTP) on locomotor activity in mice.
    Maj J; Pawlowski
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):145-9. PubMed ID: 1082126
    [No Abstract]   [Full Text] [Related]  

  • 32. Locomotion in the rat after 5-hydroxy-L-tryptophan.
    Clarke KA; Parker AJ; Stirk GC
    Eur J Pharmacol; 1984 Feb; 98(2):255-60. PubMed ID: 6609078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the effects of 5-hydroxytryptophan on the secretion of ACTH and growth hormone in dogs are not mediated by central release of serotonin.
    Zimmermann H; Kaplan SL; Ganong WF
    Neuroendocrinology; 1982 Jan; 34(1):27-31. PubMed ID: 6276803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE; Kulkarni AS
    Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
    [No Abstract]   [Full Text] [Related]  

  • 35. Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1970 Sep; 22(9):726-7. PubMed ID: 4394774
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.
    Baumann MH; Williams Z; Zolkowska D; Rothman RB
    Drug Alcohol Depend; 2011 Apr; 114(2-3):147-52. PubMed ID: 21071157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
    Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin release after 5-hydroxytryptophan treatment requires an intact neurointermediate pituitary lobe.
    Johnston CA; Fagin KD; Alper RH; Negro-Vilar A
    Endocrinology; 1986 Feb; 118(2):805-10. PubMed ID: 2417827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo.
    Esteban S; Lladó J; Sastre-Coll A; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):135-43. PubMed ID: 10494882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.